Abstract Details
|
Anson Wang, MD
(Massachusetts General Hospital)
PRESENTER |
Dr. Wang has nothing to disclose. |
| Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) | Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
| Randolph S. Marshall, MD, FAAN (Columbia University) | The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Ryan Hebert | No disclosure on file |
| No disclosure on file | |
| Nils Petersen, MD (Yale University) | Dr. Petersen has received research support from NIH. |